Summary
The product METHASTERONE, manufactured by Driada Medical, underwent laboratory testing to verify its composition and quality. The sample, identified by batch number 023805, was analyzed by Janoshik Analytical. The analysis confirmed the presence of methasterone with a measured dosage of 10.62 mg per pill, closely matching the product’s expected dosage of 10 mg. This result reflects a 6.2% variance, which indicates accurate dosing within acceptable limits.
The testing process commenced on 25 March 2022, with the sample received on 29 March 2022, and the analysis completed on 31 March 2022. The sample was both submitted and funded by Driada Medical, which warrants careful scrutiny due to potential conflicts of interest. Notably, the sample underwent two retests to ensure result reliability. This report is published for harm reduction and educational purposes, providing transparency to assist users in making informed decisions about anabolic steroid products.
Detailed Report
Product Overview
- Manufacturer: Driada Medical
- Product Name: METHASTERONE
- Active Ingredient: Methasterone
- Batch Number: 023805
- Delivery Method: Oral Tablet
Sample Acquisition and Testing
- Task Number: #19554
- Testing Ordered: 25 March 2022
- Sample Received: 29 March 2022
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Driada Medical
- Analysis Paid For By: Driada Medical
Testing Results
- Specification: 10 mg per pill
- Measured Dosage: 10.62 mg per pill
- Accuracy: 106.2% (6.2% above the label claim)
Verification Details
- Verification URL: https://janoshik.com/tests/19554_5XW9F5CJ2X8R
- Originally Published: https://thinksteroids.com/community/posts/2934375/
Evaluation of Manufacturer-Funded Testing
Given that this test was both submitted and funded by the manufacturer, Driada Medical, it is important to approach the results with a degree of caution. Potential conflicts of interest and selective sample submissions have been considered. However, Janoshik Analytical’s reputation for reliable and transparent practices lends credibility to the findings. Independent third-party testing would further substantiate these results, increasing consumer confidence in the product’s quality.
Conclusion
This analysis highlights the importance of independent laboratory testing in verifying the accuracy and quality of anabolic steroid products. The results for METHASTERONE demonstrate accurate dosing, within acceptable variance limits, confirming the product’s adherence to its stated specifications. Reports such as this play a critical role in supporting harm reduction and educating consumers in the anabolic steroid market.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-funded testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside independent results. Readers are encouraged to interpret this information responsibly.
